Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk
Zoe Moodie(Fred Hutch Cancer Center), M. Juliana McElrath(Fred Hutch Cancer Center), Kelly E. Seaton(International Vaccine Institute), Maphoshane Nchabeleng(Sefako Makgatho Health Sciences University), Mookho Malahleha(University of Cape Town), Nicole Grunenberg(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Yunda Huang(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), One Dintwe(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Glenda Gray(South African Medical Research Council), Kristen W. Cohen(Moderna Therapeutics (United States)), Thozama Dubula(Nelson Mandela Academic Hospital), Mary Allen(National Institutes of Health), David Benkeser(Emory University), James G. Kublin(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Yutong Jin(Emory University), Craig Innes(Aurum Institute), Nishanta Singh(South African Medical Research Council), Georgia D. Tomaras(National Institutes of Health), Marguerite Koutsoukos(GlaxoSmithKline (Belgium)), James Tartaglia(Sanofi (United States)), April K. Randhawa(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Linda‐Gail Bekker(Desmond Tutu HIV Foundation), Faatima Laher Omar, Holly Janes(Fred Hutch Cancer Center), Nivashnee Naicker(Centre for the AIDS Programme of Research in South Africa), Fatima Laher(University of the Witwatersrand), Philip Kotze(Jisc), Marcella Sarzotti‐Kelsoe(Duke Medical Center), Lawrence Corey(Fred Hutch Cancer Center), William Brumskine(Aurum Institute), Nicole L. Yates(Duke University), Jack Heptinstall(Duke University), Erica Andersen‐Nissen(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Vaneshree Govender(South African Medical Research Council), Erica Lazarus(Norwegian Womens Public Health Association), Peter B. Gilbert(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lindsay N. Carpp(Fred Hutch Cancer Center), Jia Jin Kee(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lu Zhang(Qingdao University of Science and Technology), Amy Ward(University of Cape Town), Stephen C. De Rosa(University of Washington), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Patricia D’Souza(National Institutes of Health), Carlos A. DiazGranados(Gates Foundation), Sheetal Kassim(Desmond Tutu HIV Foundation), Modulakgotla Sebe(Aurum Institute), Doug Grove(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Sheetal Sawant(Duke University)
Cited by 50
Related Papers
Integrated analysis of multimodal single-cell data
|Cell|2021|16.2k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k
Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa
|The Lancet|2004|1.3k
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
|New England Journal of Medicine|1990|1.3k